NDAINJECTIONINJECTABLE
Approved
Oct 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
MANNITOL 20% (mannitol) by B. Braun is osmotic activity [moa]. First approved in 1965.
Drug data last refreshed 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Mannitol 20% is an osmotic diuretic administered intravenously to reduce intracranial pressure and treat elevated intracranial hypertension in acute neurological conditions. It works by creating an osmotic gradient that draws fluid from brain tissue into the vasculature, reducing cerebral edema. The product is also used off-label for bowel preparation and constipation management.
LOE Approaching
As LOE approaches, the brand team will likely focus on defensive positioning and cost-efficiency rather than growth initiatives; expect consolidation of commercial resources.
Mechanism of Action
Osmotic Activity
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis
Started Mar 2023
14 enrolled
Cystic Fibrosis
PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction
Started Sep 2022
190 enrolled
Asthma
Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma
Started Jan 2019
40 enrolled
AsthmaCough
A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy
Started Feb 2015
184 enrolled
Bowel Preparation
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Started Sep 2014
423 enrolled
Cystic Fibrosis
Worked on MANNITOL 20% at B. Braun? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.